Hope in sight for retinoblastoma.
Sage
Julien
J
D051358:Cyclin-Dependent Kinase 4 / Q000037:antagonists & inhibitors / Q000378:metabolism; D051361:Cyclin-Dependent Kinase 6 / Q000037:antagonists & inhibitors / Q000378:metabolism; D015316:Genetic Therapy; D006801:Humans; D008954:Models, Biological; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D012175:Retinoblastoma / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D016160:Retinoblastoma Protein / Q000235:genetics / Q000502:physiology*; D000077546:Roscovitine; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics / Q000502:physiology*
D047428:Protein Kinase Inhibitors; D011687:Purines; D016160:Retinoblastoma Protein; D000077546:Roscovitine; C495900:CDK4 protein, human; C495911:CDK6 protein, human; D051358:Cyclin-Dependent Kinase 4; D051361:Cyclin-Dependent Kinase 6